BeStock  
Stocks › Biotechnology › ANRO

Alto Neuroscience ANRO

US equityMarket cap rank #3145Biotechnology
$25.37 −$1.14 (-4.30%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $25.37 0.00%
Open$25.76
Prev close$26.51
Day range$24.40 – $26.48
Volume522.5K
Market cap$1.02B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership91.0%-0.21 pts vs. prior quarter
Institutions holding153+15 vs. prior quarter
Insider trades (recent)40 buys / 9 sellsNet buying
Short interest14.48% of floatDays to cover 10.5 · as of 30 Oct 2026
Short-sale volume share18.8%5-day average of daily volume

Short-sale volume as % of daily volume

13%22%31%41%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$1.14M (10 inflow days, 10 outflow days).

Net flow by order size, last 20 sessions

−$896.8KSuper−$239.7KBig−$2.0MMid−$2.0MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 32.6% of shares outstanding.

Largest holders

  • Alpha Wave Global, LP9.24%
  • BlackRock6.80%
  • Commodore Capital LP6.79%
  • EcoR1 Capital, LLC5.56%
  • Vanguard Capital Management, LLC4.22%
  • Perceptive Advisors LLC4.01%
  • Adage Capital Management, L.P.3.99%
  • Sirenia Capital Management LP3.57%

By investor type

  • Hedge Fund46.18%
  • Mutual Fund32.00%
  • VC/PE Fund10.78%
  • Individual/Insider2.45%
  • Public Company1.51%
  • Private Company0.17%
  • Insurance Company0.14%
  • Government Pension Fund0.09%

Reported short interest has risen from 9.06% to 14.48% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Nicholas Smith Individual/Insider 2026/Q3 +55,000 0.2%
BlackRock Mutual Fund 2026/Q3 +605,097 6.8%
Invesco Capital Management LLC Mutual Fund 2026/Q3 +339,492 0.8%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +301,276 4.2%
State Street Global Advisors Mutual Fund 2026/Q3 +260,095 2.4%
Morgan Stanley Public Company 2026/Q3 +186,081 0.7%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +186,081 0.7%
Geode Capital Management, LLC Mutual Fund 2026/Q3 +154,060 2.1%
FMR Mutual Fund 2026/Q3 +144,414 0.4%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +98,940 0.7%
Harvest Investment Services, LLC Mutual Fund 2026/Q3 +63,991 0.2%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +56,133 0.1%
EcoR1 Capital, LLC Hedge Fund 2026/Q3 +2,232,000 5.6%
BlackRock Mutual Fund 2026/Q3 +1,454,821 5.4%
Adage Capital Management, L.P. Hedge Fund 2026/Q3 +1,215,000 4.0%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
1 Oct 2026 Nicholas Smith CFO & President Derivative Exercise and Retained +55,000 $2.32 79,060
29 Sep 2026 Nicholas Smith CFO & President Derivative Exercise and Sale -134,886 $26.87 24,060
28 Sep 2026 Nicholas Smith CFO & President Intent to Sell (Form 144) -134,886 $26.66 –
26 May 2026 Andrew Miller Director Other Derivative Acquisition +26,000 $20.44 26,000
13 May 2026 Amit Etkin Founder, CEO & Chairman of the Board Other Disposition -400,000 – 833,949
11 May 2026 Gwill York Independent Director Other Derivative Acquisition +10,958 $24.63 10,958
11 May 2026 Andrew Dreyfus Independent Director Other Derivative Acquisition +10,958 $24.63 10,958
11 May 2026 Husseini Manji Non-Employee Independent Director Other Derivative Acquisition +10,958 $24.63 10,958
11 May 2026 Raymond Sanchez Independent Director Other Derivative Acquisition +10,958 $24.63 10,958
11 May 2026 Christopher Cox Lead Independent Director Other Derivative Acquisition +10,958 $24.63 10,958
28 Feb 2026 Nicholas Smith CFO & President Sale to Issuer -2,806 $19.69 24,060
28 Feb 2026 Amit Etkin Founder, CEO & Chairman of the Board Sale to Issuer -6,227 $19.69 1,233,949
10 Feb 2026 Nicholas Smith CFO & President Other Derivative Acquisition +200,000 $16.71 200,000
10 Feb 2026 Amit Etkin Founder, CEO & Chairman of the Board Other Derivative Acquisition +306,000 $16.71 306,000
10 Feb 2026 Michael Hanley Chief Operating Officer Other Derivative Acquisition +131,000 $16.71 131,000
10 Feb 2026 Adam Savitz Chief Medical Officer Other Derivative Acquisition +124,000 $16.71 124,000
1 Jan 2026 Gwill York Independent Director Other Derivative Acquisition +5,243 $16.59 5,243
1 Jan 2026 Husseini Manji Non-Employee Independent Director Other Derivative Acquisition +4,228 $16.59 4,228
1 Jan 2026 Raymond Sanchez Independent Director Other Derivative Acquisition +3,806 $16.59 3,806
1 Jan 2026 Christopher Cox Lead Independent Director Other Derivative Acquisition +7,189 $16.59 7,189

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 5,682,860 14.5% 10.5
15 Oct 2026 5,204,407 13.3% 7.5
30 Sep 2026 4,660,269 11.9% 6.5
15 Sep 2026 4,174,082 10.6% 9.1
31 Aug 2026 3,836,359 9.8% 8.1
14 Aug 2026 3,556,066 9.1% 7.5

Discussion

No comments yet — be the first to weigh in on ANRO.

Sign in to join the discussion.

Scroll to Top